1st Swiss International Conference on Industrial Microbiology 2012

MICROSCON marks the beginning of a new chapter in the exploration of advances and trends in industrial microbiology. Its aim is to bring together experts from industry and academia: the conference is an interdisciplinary platform for networking, as well as discussing research and innovations that are charting the course for the future.

The conference will focus on the industrial application, exploitation, discovery and control of microorganisms. Microbiologists are not the sole audience here; other scientists from academia and industry with an interest in state-of-the-art applied and industrial microbiology will also find a warm welcome.

The presenting scientists will talk about the latest research and development work in their respective fields of microbiological expertise, including food and beverages, plants and environment, industrial manufacturing, and pharmaceuticals. Future trends and business development are further topics for attention.

While the primary goal is to promote know-how transfer from basic research to its application in industry, MICROSCON 2012 also aims to endorse and facilitate joint developments in this field. A limited number of grants will be disbursed to support the attendance of young academics.   

 Further details and to register

Read More

4th Annual Drug Development Leaders Summit, Switzerland 2012

Oxford Global Conferences are pleased to announce the 4th Annual Drug Development Leaders Summit being held in June 2012 in Switzerland.

The event offers over 250 attendees a valuable opportunity to network with senior-level decision-makers from leading pharmaceutical, biotech companies, clinical research institutions, academic and healthcare institutions working throughout the Drug Discovery & Development Value Chain.

The Pharmaceutical Industry is facing rising clinical development costs and falling drug discovery success rates. In order to stay competitive, they are re-evaluating their drug development processes and working to reduce late phase attrition rates. The industry is investing more in safety and research measures than ever before and combined with an ever-changing framework of regulation the path the market has never been more complicated or costly for key practitioners in Drug Development. There is an urgent need for improved phase processes, Partnering and Outsourcing strategies and Novel Technologies that will enable the delivery of improved drugs to market quicker and ultimately the establishment of a more robust and lean pipeline.

Do not miss out on our co-located the 13th Drug Discovery Leaders Summit, which provides a first class educational and networking opportunity for attendees to gain knowledge and insights into the entire Drug Discovery marketplace.

Further details and to register

Read More

Switzerland: 4th Annual Drug Development Summit 2012

Over 250 attendees

Over 35 outstanding presentation/panel discussions

4 interactive streams:
• Translational Biomarkers for Safer Drugs
• PK/PD Value and Strategies
• Improving Global Drug Development: Regulation Guidelines, Risk Management and CRO Selection
• Modeling Methods – Early Toxicity Risk Discharge

14 pre-scheduled one to one business meetings & exhibition

Co-located with the 13th Annual Drug Discovery Leaders Summit

Oxford Global Conferences are pleased to announce the 4th Annual Drug Development Leaders Summit being held in June 2012 in Switzerland. The event offers over 250 attendees a valuable opportunity to network with senior-level decision-makers from leading pharmaceutical, biotech companies, clinical research institutions, academic and healthcare institutions working throughout the Drug Discovery & Development Value Chain.

The Pharmaceutical Industry is facing rising clinical development costs and falling drug discovery success rates. In order to stay competitive, they are re-evaluating their drug development processes and working to reduce late phase attrition rates. The industry is investing more in safety and research measures than ever before and combined with an ever-changing framework of regulation the path the market has never been more complicated or costly for key practitioners in Drug Development. There is an urgent need for improved phase processes, Partnering and Outsourcing strategies and Novel Technologies that will enable the delivery of improved drugs to market quicker and ultimately the establishment of a more robust and lean pipeline.

Do not miss out on our co-located the 13th Drug Discovery Leaders Summit, which provides a first class educational and networking opportunity for attendees to gain knowledge and insights into the entire Drug Discovery marketplace.

Further Conference Details

Read More

1st Swiss International Conference on Industrial Microbiology - Switzerland

The Microscon is the beginning of a new chapter in the exploration of advances and trends in Industrial Microbiology with the aim of bringing together the experts from industry and academia. The conference is an interdisciplinary platform for networking and to discuss research and innovations that are charting the course for the future

- Food and beverage microbiology
- Plant and Environmental Microbiology
- Industrial, Manufacturing and Pharmaceutical Microbiology
- Future Trends and Business Development

Conference on october 2012 16-17

More Details on Conference

Read More

MipTec 2011 - Premier European drug discovery event

Welcome to the 2011 MipTec, the premier European drug discovery event.

This year MipTec returns to the Basel Congress Center and the more focused location and format of previous years.

Read More